See every side of every news story
Get Started
SubscribeLogin
Published • loading... • Updated

Imfinzi, First and only Perioperative Immunotherapy to Be Approved in the Treatment of Bladder Cancer with Muscle Invasion

Summary by Newswire
/CNW/ - Health Canada has issued a Notice of Compliance for Imfinzi® (durvalumab) for the treatment of patients with bladder cancer with...
DisclaimerThis story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.

1 Articles

NewswireNewswire

Imfinzi, First and only Perioperative Immunotherapy to Be Approved in the Treatment of Bladder Cancer with Muscle Invasion

/CNW/ - Health Canada has issued a Notice of Compliance for Imfinzi® (durvalumab) for the treatment of patients with bladder cancer with...

Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • There is no tracked Bias information for the sources covering this story.

Factuality 

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

Newswire broke the news in on Wednesday, August 6, 2025.
Sources are mostly out of (0)
Stories disproportionately reported by the Left or the Right

Similar News Topics

Health Canada icon

Health Canada

Canada icon

Canada

News
For You
SearchBlindspotLocal